Molecular mechanisms of paraptosis induction: implications for a non-genetically modified tumor vaccine

Neil Hoa1, Michael P Myers, Thomas G Douglass

  • 1Diagnostic and Molecular Medicine Healthcare Group, Veterans Affairs Medical Center, Long Beach, California, United States of America.

Plos One
|February 28, 2009
PubMed

Insights

Programmed cell death (paraptosis) in glioma cells can be triggered by activating large potassium channels (BK channels). This process enhances tumor immunogenicity, offering potential for cancer immunotherapy.

Area of Science:

  • Cell Biology
  • Immunology
  • Neuro-oncology

Background:

  • Paraptosis, a programmed cell death pathway, involves cellular necrosis.
  • Previous studies showed macrophages induce paraptosis in glioma cells but lacked mechanistic insight.
  • The molecular mechanisms underlying macrophage-mediated glioma cell killing via paraptosis remained unidentified.

Purpose of the Study:

  • To elucidate the molecular mechanism of paraptosis in rat T9 glioma cells.
  • To investigate the role of large-conductance potassium channels (BK channels) in glioma cell death.
  • To evaluate the immunogenicity of glioma cells undergoing BK channel-induced paraptosis.

Main Methods:

  • Utilized fluorescent confocal and electron microscopy, flow cytometry, and electrophysiology.
  • Employed pharmacological agents and genetic knock-down techniques to study BK channel function.
  • Assessed heat shock protein expression, HMGB1 translocation, and ATP levels in treated glioma cells.

Main Results:

  • Demonstrated that BK channel activation, initiated by reactive oxygen species, induces paraptosis in T9 glioma cells.
  • Observed that BK channel activation leads to cellular swelling, vacuolization, and ATP depletion.
  • Showed that BK channel activation upregulates heat shock proteins and causes HMGB1 translocation, enhancing tumor immunogenicity and inducing a protective immune response in rats.

Conclusions:

  • Prolonged BK channel activation induces paraptosis in glioma cells, enhancing their immunogenicity.
  • This BK channel-dependent cell death mechanism reproduces the vaccinating effects observed with macrophage colony-stimulating factor (mM-CSF) transduced cells.
  • Findings suggest that targeting BK channels could be a valuable strategy for developing clinical cancer immunotherapy.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...